Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 3
2019 3
2020 1
2021 3
2022 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Results by year

Filters applied: . Clear all
Page 1
Different Effects of Lifestyle Intervention in High- and Low-Risk Prediabetes: Results of the Randomized Controlled Prediabetes Lifestyle Intervention Study (PLIS).
Fritsche A, Wagner R, Heni M, Kantartzis K, Machann J, Schick F, Lehmann R, Peter A, Dannecker C, Fritsche L, Valenta V, Schick R, Nawroth PP, Kopf S, Pfeiffer AFH, Kabisch S, Dambeck U, Stumvoll M, Blüher M, Birkenfeld AL, Schwarz P, Hauner H, Clavel J, Seißler J, Lechner A, Müssig K, Weber K, Laxy M, Bornstein S, Schürmann A, Roden M, de Angelis MH, Stefan N, Häring HU. Fritsche A, et al. Among authors: dambeck u. Diabetes. 2021 Dec;70(12):2785-2795. doi: 10.2337/db21-0526. Epub 2021 Sep 16. Diabetes. 2021. PMID: 34531293 Clinical Trial.
Low IGF1 and high IGFBP1 predict diabetes onset in prediabetic patients.
Meyer NMT, Kabisch S, Dambeck U, Honsek C, Kemper M, Gerbracht C, Arafat AM, Birkenfeld AL, Schwarz PEH, Machann J, Osterhoff MA, Weickert MO, Pfeiffer AFH. Meyer NMT, et al. Among authors: dambeck u. Eur J Endocrinol. 2022 Sep 19;187(4):555-565. doi: 10.1530/EJE-22-0034. Print 2022 Oct 1. Eur J Endocrinol. 2022. PMID: 36005859
Effects of Insoluble Cereal Fibre on Body Fat Distribution in the Optimal Fibre Trial.
Kabisch S, Honsek C, Kemper M, Gerbracht C, Meyer NMT, Arafat AM, Birkenfeld AL, Machann J, Dambeck U, Osterhoff MA, Weickert MO, Pfeiffer AFH. Kabisch S, et al. Among authors: dambeck u. Mol Nutr Food Res. 2021 Jun;65(12):e2000991. doi: 10.1002/mnfr.202000991. Epub 2021 May 16. Mol Nutr Food Res. 2021. PMID: 33909947 Clinical Trial.
Fibre supplementation for the prevention of type 2 diabetes and improvement of glucose metabolism: the randomised controlled Optimal Fibre Trial (OptiFiT).
Honsek C, Kabisch S, Kemper M, Gerbracht C, Arafat AM, Birkenfeld AL, Dambeck U, Osterhoff MA, Weickert MO, Pfeiffer AFH. Honsek C, et al. Among authors: dambeck u. Diabetologia. 2018 Jun;61(6):1295-1305. doi: 10.1007/s00125-018-4582-6. Epub 2018 Feb 28. Diabetologia. 2018. PMID: 29492637 Clinical Trial.
11 results